Global Non-opioid Analgesic Patch Market Growth 2025-2031
The global Non-opioid Analgesic Patch market size is predicted to grow from US$ 3330 million in 2025 to US$ 5013 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid analgesic patch is a transdermal delivery system that administers pain-relieving medication directly through the skin without using opioids. It typically contains non-narcotic agents such as non-steroidal anti-inflammatory drugs (NSAIDs) or other alternative analgesics, which provide targeted, sustained relief for localized pain conditions. By releasing the active ingredient steadily over several hours, these patches help maintain consistent therapeutic levels at the site of pain, reducing the need for frequent dosing and minimizing systemic side effects. This method of pain management offers an effective and safer alternative to opioid-based treatments, lowering the risk of dependency and adverse reactions while improving patient compliance and comfort.
The global Non-opioid Analgesic Patch market is experiencing steady growth, driven by the increasing demand for safer and non-addictive pain management solutions. Rising awareness of the risks associated with opioid medications, particularly the opioid crisis in North America, has accelerated the shift toward alternative pain relief options. These patches, typically containing NSAIDs (e.g., diclofenac or ketoprofen), lidocaine, or herbal actives, are gaining popularity due to their targeted delivery, minimal systemic exposure, and ease of use.
Regional dynamics highlight strong demand in North America, which remains the largest market due to healthcare awareness and reimbursement policies. Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure in China and India, and increasing consumer preference for over-the-counter pain relief products. Europe also shows stable demand, particularly in countries with aging populations such as Germany, Italy, and France.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Analgesic Patch Industry Forecast” looks at past sales and reviews total world Non-opioid Analgesic Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Analgesic Patch sales for 2025 through 2031. With Non-opioid Analgesic Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Analgesic Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Analgesic Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Analgesic Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Analgesic Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Analgesic Patch and breaks down the forecast by Product, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Analgesic Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Analgesic Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Product:
What is the 10-year outlook for the global Non-opioid Analgesic Patch market?
What factors are driving Non-opioid Analgesic Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Analgesic Patch market opportunities vary by end market size?
How does Non-opioid Analgesic Patch break out by Product, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A non-opioid analgesic patch is a transdermal delivery system that administers pain-relieving medication directly through the skin without using opioids. It typically contains non-narcotic agents such as non-steroidal anti-inflammatory drugs (NSAIDs) or other alternative analgesics, which provide targeted, sustained relief for localized pain conditions. By releasing the active ingredient steadily over several hours, these patches help maintain consistent therapeutic levels at the site of pain, reducing the need for frequent dosing and minimizing systemic side effects. This method of pain management offers an effective and safer alternative to opioid-based treatments, lowering the risk of dependency and adverse reactions while improving patient compliance and comfort.
The global Non-opioid Analgesic Patch market is experiencing steady growth, driven by the increasing demand for safer and non-addictive pain management solutions. Rising awareness of the risks associated with opioid medications, particularly the opioid crisis in North America, has accelerated the shift toward alternative pain relief options. These patches, typically containing NSAIDs (e.g., diclofenac or ketoprofen), lidocaine, or herbal actives, are gaining popularity due to their targeted delivery, minimal systemic exposure, and ease of use.
Regional dynamics highlight strong demand in North America, which remains the largest market due to healthcare awareness and reimbursement policies. Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure in China and India, and increasing consumer preference for over-the-counter pain relief products. Europe also shows stable demand, particularly in countries with aging populations such as Germany, Italy, and France.
LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Analgesic Patch Industry Forecast” looks at past sales and reviews total world Non-opioid Analgesic Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Analgesic Patch sales for 2025 through 2031. With Non-opioid Analgesic Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Analgesic Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Analgesic Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Analgesic Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Analgesic Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Analgesic Patch and breaks down the forecast by Product, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Analgesic Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Analgesic Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Product:
- Lidocaine Patch
- Diclofenac Patch
- Methyl Salicylate Patch
- Capsaicin Patch
- Ketoprofen Patch
- Others
- Hospitals and Clinics
- Retail Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hisamitsu Pharmaceutical
- Haleon
- Teikoku Seiyaku
- Viatris
- Kenvue
- Johnson & Johnson
- Teva Pharmaceuticals
- Grunenthal
- Averitas Pharma
- Nitto Denko
- IBSA Pharma
- Teh Seng Pharmaceutical Mfg
- BBCT Pharmaceutical
- Beijing Tide Pharmaceutical
- Jiudian Pharmaceutical
- Yunnan Baiyao
- Lingrui Pharmaceutical
- Anhui Jinma Pharmaceutical
- Guizhou Liansheng Pharmaceutical
- Yabao Pharmaceutical
What is the 10-year outlook for the global Non-opioid Analgesic Patch market?
What factors are driving Non-opioid Analgesic Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Analgesic Patch market opportunities vary by end market size?
How does Non-opioid Analgesic Patch break out by Product, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-opioid Analgesic Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non-opioid Analgesic Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non-opioid Analgesic Patch by Country/Region, 2020, 2024 & 2031
2.2 Non-opioid Analgesic Patch Segment by Product
2.2.1 Lidocaine Patch
2.2.2 Diclofenac Patch
2.2.3 Methyl Salicylate Patch
2.2.4 Capsaicin Patch
2.2.5 Ketoprofen Patch
2.2.6 Others
2.3 Non-opioid Analgesic Patch Sales by Product
2.3.1 Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
2.3.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Product (2020-2025)
2.3.3 Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025)
2.4 Non-opioid Analgesic Patch Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Non-opioid Analgesic Patch Sales by Application
2.5.1 Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non-opioid Analgesic Patch Breakdown Data by Company
3.1.1 Global Non-opioid Analgesic Patch Annual Sales by Company (2020-2025)
3.1.2 Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
3.2 Global Non-opioid Analgesic Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Non-opioid Analgesic Patch Revenue by Company (2020-2025)
3.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
3.3 Global Non-opioid Analgesic Patch Sale Price by Company
3.4 Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Analgesic Patch Product Location Distribution
3.4.2 Players Non-opioid Analgesic Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID ANALGESIC PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-opioid Analgesic Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Non-opioid Analgesic Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non-opioid Analgesic Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-opioid Analgesic Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Non-opioid Analgesic Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non-opioid Analgesic Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-opioid Analgesic Patch Sales Growth
4.4 APAC Non-opioid Analgesic Patch Sales Growth
4.5 Europe Non-opioid Analgesic Patch Sales Growth
4.6 Middle East & Africa Non-opioid Analgesic Patch Sales Growth
5 AMERICAS
5.1 Americas Non-opioid Analgesic Patch Sales by Country
5.1.1 Americas Non-opioid Analgesic Patch Sales by Country (2020-2025)
5.1.2 Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025)
5.2 Americas Non-opioid Analgesic Patch Sales by Product (2020-2025)
5.3 Americas Non-opioid Analgesic Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Analgesic Patch Sales by Region
6.1.1 APAC Non-opioid Analgesic Patch Sales by Region (2020-2025)
6.1.2 APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025)
6.2 APAC Non-opioid Analgesic Patch Sales by Product (2020-2025)
6.3 APAC Non-opioid Analgesic Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-opioid Analgesic Patch by Country
7.1.1 Europe Non-opioid Analgesic Patch Sales by Country (2020-2025)
7.1.2 Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025)
7.2 Europe Non-opioid Analgesic Patch Sales by Product (2020-2025)
7.3 Europe Non-opioid Analgesic Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-opioid Analgesic Patch by Country
8.1.1 Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025)
8.3 Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch
10.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
10.4 Industry Chain Structure of Non-opioid Analgesic Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Analgesic Patch Distributors
11.3 Non-opioid Analgesic Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID ANALGESIC PATCH BY GEOGRAPHIC REGION
12.1 Global Non-opioid Analgesic Patch Market Size Forecast by Region
12.1.1 Global Non-opioid Analgesic Patch Forecast by Region (2026-2031)
12.1.2 Global Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-opioid Analgesic Patch Forecast by Product (2026-2031)
12.7 Global Non-opioid Analgesic Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.1.3 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Haleon
13.2.1 Haleon Company Information
13.2.2 Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
13.2.3 Haleon Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Haleon Main Business Overview
13.2.5 Haleon Latest Developments
13.3 Teikoku Seiyaku
13.3.1 Teikoku Seiyaku Company Information
13.3.2 Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
13.3.3 Teikoku Seiyaku Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teikoku Seiyaku Main Business Overview
13.3.5 Teikoku Seiyaku Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
13.4.3 Viatris Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 Kenvue
13.5.1 Kenvue Company Information
13.5.2 Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
13.5.3 Kenvue Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kenvue Main Business Overview
13.5.5 Kenvue Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Non-opioid Analgesic Patch Product Portfolios and Specifications
13.6.3 Johnson & Johnson Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Teva Pharmaceuticals
13.7.1 Teva Pharmaceuticals Company Information
13.7.2 Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
13.7.3 Teva Pharmaceuticals Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceuticals Main Business Overview
13.7.5 Teva Pharmaceuticals Latest Developments
13.8 Grunenthal
13.8.1 Grunenthal Company Information
13.8.2 Grunenthal Non-opioid Analgesic Patch Product Portfolios and Specifications
13.8.3 Grunenthal Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Grunenthal Main Business Overview
13.8.5 Grunenthal Latest Developments
13.9 Averitas Pharma
13.9.1 Averitas Pharma Company Information
13.9.2 Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
13.9.3 Averitas Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Averitas Pharma Main Business Overview
13.9.5 Averitas Pharma Latest Developments
13.10 Nitto Denko
13.10.1 Nitto Denko Company Information
13.10.2 Nitto Denko Non-opioid Analgesic Patch Product Portfolios and Specifications
13.10.3 Nitto Denko Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nitto Denko Main Business Overview
13.10.5 Nitto Denko Latest Developments
13.11 IBSA Pharma
13.11.1 IBSA Pharma Company Information
13.11.2 IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
13.11.3 IBSA Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IBSA Pharma Main Business Overview
13.11.5 IBSA Pharma Latest Developments
13.12 Teh Seng Pharmaceutical Mfg
13.12.1 Teh Seng Pharmaceutical Mfg Company Information
13.12.2 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolios and Specifications
13.12.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Teh Seng Pharmaceutical Mfg Main Business Overview
13.12.5 Teh Seng Pharmaceutical Mfg Latest Developments
13.13 BBCT Pharmaceutical
13.13.1 BBCT Pharmaceutical Company Information
13.13.2 BBCT Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.13.3 BBCT Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 BBCT Pharmaceutical Main Business Overview
13.13.5 BBCT Pharmaceutical Latest Developments
13.14 Beijing Tide Pharmaceutical
13.14.1 Beijing Tide Pharmaceutical Company Information
13.14.2 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.14.3 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Beijing Tide Pharmaceutical Main Business Overview
13.14.5 Beijing Tide Pharmaceutical Latest Developments
13.15 Jiudian Pharmaceutical
13.15.1 Jiudian Pharmaceutical Company Information
13.15.2 Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.15.3 Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jiudian Pharmaceutical Main Business Overview
13.15.5 Jiudian Pharmaceutical Latest Developments
13.16 Yunnan Baiyao
13.16.1 Yunnan Baiyao Company Information
13.16.2 Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
13.16.3 Yunnan Baiyao Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Yunnan Baiyao Main Business Overview
13.16.5 Yunnan Baiyao Latest Developments
13.17 Lingrui Pharmaceutical
13.17.1 Lingrui Pharmaceutical Company Information
13.17.2 Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.17.3 Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Lingrui Pharmaceutical Main Business Overview
13.17.5 Lingrui Pharmaceutical Latest Developments
13.18 Anhui Jinma Pharmaceutical
13.18.1 Anhui Jinma Pharmaceutical Company Information
13.18.2 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.18.3 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Anhui Jinma Pharmaceutical Main Business Overview
13.18.5 Anhui Jinma Pharmaceutical Latest Developments
13.19 Guizhou Liansheng Pharmaceutical
13.19.1 Guizhou Liansheng Pharmaceutical Company Information
13.19.2 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.19.3 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Guizhou Liansheng Pharmaceutical Main Business Overview
13.19.5 Guizhou Liansheng Pharmaceutical Latest Developments
13.20 Yabao Pharmaceutical
13.20.1 Yabao Pharmaceutical Company Information
13.20.2 Yabao Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.20.3 Yabao Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Yabao Pharmaceutical Main Business Overview
13.20.5 Yabao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-opioid Analgesic Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Non-opioid Analgesic Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Non-opioid Analgesic Patch by Country/Region, 2020, 2024 & 2031
2.2 Non-opioid Analgesic Patch Segment by Product
2.2.1 Lidocaine Patch
2.2.2 Diclofenac Patch
2.2.3 Methyl Salicylate Patch
2.2.4 Capsaicin Patch
2.2.5 Ketoprofen Patch
2.2.6 Others
2.3 Non-opioid Analgesic Patch Sales by Product
2.3.1 Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
2.3.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Product (2020-2025)
2.3.3 Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025)
2.4 Non-opioid Analgesic Patch Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Non-opioid Analgesic Patch Sales by Application
2.5.1 Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Non-opioid Analgesic Patch Breakdown Data by Company
3.1.1 Global Non-opioid Analgesic Patch Annual Sales by Company (2020-2025)
3.1.2 Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
3.2 Global Non-opioid Analgesic Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Non-opioid Analgesic Patch Revenue by Company (2020-2025)
3.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
3.3 Global Non-opioid Analgesic Patch Sale Price by Company
3.4 Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Analgesic Patch Product Location Distribution
3.4.2 Players Non-opioid Analgesic Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-OPIOID ANALGESIC PATCH BY GEOGRAPHIC REGION
4.1 World Historic Non-opioid Analgesic Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Non-opioid Analgesic Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Non-opioid Analgesic Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Non-opioid Analgesic Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Non-opioid Analgesic Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Non-opioid Analgesic Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-opioid Analgesic Patch Sales Growth
4.4 APAC Non-opioid Analgesic Patch Sales Growth
4.5 Europe Non-opioid Analgesic Patch Sales Growth
4.6 Middle East & Africa Non-opioid Analgesic Patch Sales Growth
5 AMERICAS
5.1 Americas Non-opioid Analgesic Patch Sales by Country
5.1.1 Americas Non-opioid Analgesic Patch Sales by Country (2020-2025)
5.1.2 Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025)
5.2 Americas Non-opioid Analgesic Patch Sales by Product (2020-2025)
5.3 Americas Non-opioid Analgesic Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Analgesic Patch Sales by Region
6.1.1 APAC Non-opioid Analgesic Patch Sales by Region (2020-2025)
6.1.2 APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025)
6.2 APAC Non-opioid Analgesic Patch Sales by Product (2020-2025)
6.3 APAC Non-opioid Analgesic Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-opioid Analgesic Patch by Country
7.1.1 Europe Non-opioid Analgesic Patch Sales by Country (2020-2025)
7.1.2 Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025)
7.2 Europe Non-opioid Analgesic Patch Sales by Product (2020-2025)
7.3 Europe Non-opioid Analgesic Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-opioid Analgesic Patch by Country
8.1.1 Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025)
8.3 Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch
10.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
10.4 Industry Chain Structure of Non-opioid Analgesic Patch
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Analgesic Patch Distributors
11.3 Non-opioid Analgesic Patch Customer
12 WORLD FORECAST REVIEW FOR NON-OPIOID ANALGESIC PATCH BY GEOGRAPHIC REGION
12.1 Global Non-opioid Analgesic Patch Market Size Forecast by Region
12.1.1 Global Non-opioid Analgesic Patch Forecast by Region (2026-2031)
12.1.2 Global Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Non-opioid Analgesic Patch Forecast by Product (2026-2031)
12.7 Global Non-opioid Analgesic Patch Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.1.3 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Haleon
13.2.1 Haleon Company Information
13.2.2 Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
13.2.3 Haleon Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Haleon Main Business Overview
13.2.5 Haleon Latest Developments
13.3 Teikoku Seiyaku
13.3.1 Teikoku Seiyaku Company Information
13.3.2 Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
13.3.3 Teikoku Seiyaku Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teikoku Seiyaku Main Business Overview
13.3.5 Teikoku Seiyaku Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
13.4.3 Viatris Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 Kenvue
13.5.1 Kenvue Company Information
13.5.2 Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
13.5.3 Kenvue Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kenvue Main Business Overview
13.5.5 Kenvue Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Non-opioid Analgesic Patch Product Portfolios and Specifications
13.6.3 Johnson & Johnson Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Teva Pharmaceuticals
13.7.1 Teva Pharmaceuticals Company Information
13.7.2 Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
13.7.3 Teva Pharmaceuticals Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Teva Pharmaceuticals Main Business Overview
13.7.5 Teva Pharmaceuticals Latest Developments
13.8 Grunenthal
13.8.1 Grunenthal Company Information
13.8.2 Grunenthal Non-opioid Analgesic Patch Product Portfolios and Specifications
13.8.3 Grunenthal Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Grunenthal Main Business Overview
13.8.5 Grunenthal Latest Developments
13.9 Averitas Pharma
13.9.1 Averitas Pharma Company Information
13.9.2 Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
13.9.3 Averitas Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Averitas Pharma Main Business Overview
13.9.5 Averitas Pharma Latest Developments
13.10 Nitto Denko
13.10.1 Nitto Denko Company Information
13.10.2 Nitto Denko Non-opioid Analgesic Patch Product Portfolios and Specifications
13.10.3 Nitto Denko Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nitto Denko Main Business Overview
13.10.5 Nitto Denko Latest Developments
13.11 IBSA Pharma
13.11.1 IBSA Pharma Company Information
13.11.2 IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
13.11.3 IBSA Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IBSA Pharma Main Business Overview
13.11.5 IBSA Pharma Latest Developments
13.12 Teh Seng Pharmaceutical Mfg
13.12.1 Teh Seng Pharmaceutical Mfg Company Information
13.12.2 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolios and Specifications
13.12.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Teh Seng Pharmaceutical Mfg Main Business Overview
13.12.5 Teh Seng Pharmaceutical Mfg Latest Developments
13.13 BBCT Pharmaceutical
13.13.1 BBCT Pharmaceutical Company Information
13.13.2 BBCT Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.13.3 BBCT Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 BBCT Pharmaceutical Main Business Overview
13.13.5 BBCT Pharmaceutical Latest Developments
13.14 Beijing Tide Pharmaceutical
13.14.1 Beijing Tide Pharmaceutical Company Information
13.14.2 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.14.3 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Beijing Tide Pharmaceutical Main Business Overview
13.14.5 Beijing Tide Pharmaceutical Latest Developments
13.15 Jiudian Pharmaceutical
13.15.1 Jiudian Pharmaceutical Company Information
13.15.2 Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.15.3 Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jiudian Pharmaceutical Main Business Overview
13.15.5 Jiudian Pharmaceutical Latest Developments
13.16 Yunnan Baiyao
13.16.1 Yunnan Baiyao Company Information
13.16.2 Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
13.16.3 Yunnan Baiyao Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Yunnan Baiyao Main Business Overview
13.16.5 Yunnan Baiyao Latest Developments
13.17 Lingrui Pharmaceutical
13.17.1 Lingrui Pharmaceutical Company Information
13.17.2 Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.17.3 Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Lingrui Pharmaceutical Main Business Overview
13.17.5 Lingrui Pharmaceutical Latest Developments
13.18 Anhui Jinma Pharmaceutical
13.18.1 Anhui Jinma Pharmaceutical Company Information
13.18.2 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.18.3 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Anhui Jinma Pharmaceutical Main Business Overview
13.18.5 Anhui Jinma Pharmaceutical Latest Developments
13.19 Guizhou Liansheng Pharmaceutical
13.19.1 Guizhou Liansheng Pharmaceutical Company Information
13.19.2 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.19.3 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Guizhou Liansheng Pharmaceutical Main Business Overview
13.19.5 Guizhou Liansheng Pharmaceutical Latest Developments
13.20 Yabao Pharmaceutical
13.20.1 Yabao Pharmaceutical Company Information
13.20.2 Yabao Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
13.20.3 Yabao Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Yabao Pharmaceutical Main Business Overview
13.20.5 Yabao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-opioid Analgesic Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Analgesic Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patch
Table 4. Major Players of Diclofenac Patch
Table 5. Major Players of Methyl Salicylate Patch
Table 6. Major Players of Capsaicin Patch
Table 7. Major Players of Ketoprofen Patch
Table 8. Major Players of Others
Table 9. Global Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 10. Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Table 11. Global Non-opioid Analgesic Patch Revenue by Product (2020-2025) & ($ million)
Table 12. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
Table 13. Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025) & (US$/Dose)
Table 14. Global Non-opioid Analgesic Patch Sale by Application (2020-2025) & (K Dose)
Table 15. Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Analgesic Patch Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025) & (US$/Dose)
Table 19. Global Non-opioid Analgesic Patch Sales by Company (2020-2025) & (K Dose)
Table 20. Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Analgesic Patch Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Analgesic Patch Sale Price by Company (2020-2025) & (US$/Dose)
Table 24. Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Analgesic Patch Products Offered
Table 26. Non-opioid Analgesic Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Analgesic Patch Sales by Geographic Region (2020-2025) & (K Dose)
Table 30. Global Non-opioid Analgesic Patch Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Analgesic Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Analgesic Patch Sales by Country/Region (2020-2025) & (K Dose)
Table 34. Global Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Analgesic Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Analgesic Patch Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 38. Americas Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 41. Americas Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 42. APAC Non-opioid Analgesic Patch Sales by Region (2020-2025) & (K Dose)
Table 43. APAC Non-opioid Analgesic Patch Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 46. APAC Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 47. Europe Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 48. Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 50. Europe Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 51. Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 52. Middle East & Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 54. Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Analgesic Patch
Table 56. Key Market Challenges & Risks of Non-opioid Analgesic Patch
Table 57. Key Industry Trends of Non-opioid Analgesic Patch
Table 58. Non-opioid Analgesic Patch Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Analgesic Patch Distributors List
Table 61. Non-opioid Analgesic Patch Customer List
Table 62. Global Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Americas Non-opioid Analgesic Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (K Dose)
Table 67. APAC Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 69. Europe Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 71. Middle East & Africa Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Analgesic Patch Sales Forecast by Product (2026-2031) & (K Dose)
Table 73. Global Non-opioid Analgesic Patch Revenue Forecast by Product (2026-2031) & ($ millions)
Table 74. Global Non-opioid Analgesic Patch Sales Forecast by Application (2026-2031) & (K Dose)
Table 75. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Hisamitsu Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 77. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 78. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 79. Hisamitsu Pharmaceutical Main Business
Table 80. Hisamitsu Pharmaceutical Latest Developments
Table 81. Haleon Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 82. Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 83. Haleon Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 84. Haleon Main Business
Table 85. Haleon Latest Developments
Table 86. Teikoku Seiyaku Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 87. Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 88. Teikoku Seiyaku Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 89. Teikoku Seiyaku Main Business
Table 90. Teikoku Seiyaku Latest Developments
Table 91. Viatris Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 92. Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 93. Viatris Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 94. Viatris Main Business
Table 95. Viatris Latest Developments
Table 96. Kenvue Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 97. Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 98. Kenvue Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 99. Kenvue Main Business
Table 100. Kenvue Latest Developments
Table 101. Johnson & Johnson Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 103. Johnson & Johnson Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Teva Pharmaceuticals Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 107. Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 108. Teva Pharmaceuticals Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 109. Teva Pharmaceuticals Main Business
Table 110. Teva Pharmaceuticals Latest Developments
Table 111. Grunenthal Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 112. Grunenthal Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 113. Grunenthal Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 114. Grunenthal Main Business
Table 115. Grunenthal Latest Developments
Table 116. Averitas Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 117. Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 118. Averitas Pharma Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 119. Averitas Pharma Main Business
Table 120. Averitas Pharma Latest Developments
Table 121. Nitto Denko Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 122. Nitto Denko Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 123. Nitto Denko Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 124. Nitto Denko Main Business
Table 125. Nitto Denko Latest Developments
Table 126. IBSA Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 127. IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 128. IBSA Pharma Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 129. IBSA Pharma Main Business
Table 130. IBSA Pharma Latest Developments
Table 131. Teh Seng Pharmaceutical Mfg Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 132. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 133. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 134. Teh Seng Pharmaceutical Mfg Main Business
Table 135. Teh Seng Pharmaceutical Mfg Latest Developments
Table 136. BBCT Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 137. BBCT Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 138. BBCT Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 139. BBCT Pharmaceutical Main Business
Table 140. BBCT Pharmaceutical Latest Developments
Table 141. Beijing Tide Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 142. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 143. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 144. Beijing Tide Pharmaceutical Main Business
Table 145. Beijing Tide Pharmaceutical Latest Developments
Table 146. Jiudian Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 147. Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 148. Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 149. Jiudian Pharmaceutical Main Business
Table 150. Jiudian Pharmaceutical Latest Developments
Table 151. Yunnan Baiyao Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 152. Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 153. Yunnan Baiyao Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 154. Yunnan Baiyao Main Business
Table 155. Yunnan Baiyao Latest Developments
Table 156. Lingrui Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 157. Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 158. Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 159. Lingrui Pharmaceutical Main Business
Table 160. Lingrui Pharmaceutical Latest Developments
Table 161. Anhui Jinma Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 162. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 163. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 164. Anhui Jinma Pharmaceutical Main Business
Table 165. Anhui Jinma Pharmaceutical Latest Developments
Table 166. Guizhou Liansheng Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 167. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 168. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 169. Guizhou Liansheng Pharmaceutical Main Business
Table 170. Guizhou Liansheng Pharmaceutical Latest Developments
Table 171. Yabao Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 172. Yabao Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 173. Yabao Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 174. Yabao Pharmaceutical Main Business
Table 175. Yabao Pharmaceutical Latest Developments
Table 1. Non-opioid Analgesic Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Non-opioid Analgesic Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lidocaine Patch
Table 4. Major Players of Diclofenac Patch
Table 5. Major Players of Methyl Salicylate Patch
Table 6. Major Players of Capsaicin Patch
Table 7. Major Players of Ketoprofen Patch
Table 8. Major Players of Others
Table 9. Global Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 10. Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Table 11. Global Non-opioid Analgesic Patch Revenue by Product (2020-2025) & ($ million)
Table 12. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
Table 13. Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025) & (US$/Dose)
Table 14. Global Non-opioid Analgesic Patch Sale by Application (2020-2025) & (K Dose)
Table 15. Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
Table 16. Global Non-opioid Analgesic Patch Revenue by Application (2020-2025) & ($ million)
Table 17. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2020-2025)
Table 18. Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025) & (US$/Dose)
Table 19. Global Non-opioid Analgesic Patch Sales by Company (2020-2025) & (K Dose)
Table 20. Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
Table 21. Global Non-opioid Analgesic Patch Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
Table 23. Global Non-opioid Analgesic Patch Sale Price by Company (2020-2025) & (US$/Dose)
Table 24. Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Analgesic Patch Products Offered
Table 26. Non-opioid Analgesic Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Non-opioid Analgesic Patch Sales by Geographic Region (2020-2025) & (K Dose)
Table 30. Global Non-opioid Analgesic Patch Sales Market Share Geographic Region (2020-2025)
Table 31. Global Non-opioid Analgesic Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Non-opioid Analgesic Patch Sales by Country/Region (2020-2025) & (K Dose)
Table 34. Global Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020-2025)
Table 35. Global Non-opioid Analgesic Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Non-opioid Analgesic Patch Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 38. Americas Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
Table 39. Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 41. Americas Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 42. APAC Non-opioid Analgesic Patch Sales by Region (2020-2025) & (K Dose)
Table 43. APAC Non-opioid Analgesic Patch Sales Market Share by Region (2020-2025)
Table 44. APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 46. APAC Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 47. Europe Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 48. Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 50. Europe Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 51. Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025) & (K Dose)
Table 52. Middle East & Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025) & (K Dose)
Table 54. Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025) & (K Dose)
Table 55. Key Market Drivers & Growth Opportunities of Non-opioid Analgesic Patch
Table 56. Key Market Challenges & Risks of Non-opioid Analgesic Patch
Table 57. Key Industry Trends of Non-opioid Analgesic Patch
Table 58. Non-opioid Analgesic Patch Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Non-opioid Analgesic Patch Distributors List
Table 61. Non-opioid Analgesic Patch Customer List
Table 62. Global Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (K Dose)
Table 63. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 65. Americas Non-opioid Analgesic Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (K Dose)
Table 67. APAC Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 69. Europe Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (K Dose)
Table 71. Middle East & Africa Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Non-opioid Analgesic Patch Sales Forecast by Product (2026-2031) & (K Dose)
Table 73. Global Non-opioid Analgesic Patch Revenue Forecast by Product (2026-2031) & ($ millions)
Table 74. Global Non-opioid Analgesic Patch Sales Forecast by Application (2026-2031) & (K Dose)
Table 75. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Hisamitsu Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 77. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 78. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 79. Hisamitsu Pharmaceutical Main Business
Table 80. Hisamitsu Pharmaceutical Latest Developments
Table 81. Haleon Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 82. Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 83. Haleon Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 84. Haleon Main Business
Table 85. Haleon Latest Developments
Table 86. Teikoku Seiyaku Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 87. Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 88. Teikoku Seiyaku Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 89. Teikoku Seiyaku Main Business
Table 90. Teikoku Seiyaku Latest Developments
Table 91. Viatris Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 92. Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 93. Viatris Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 94. Viatris Main Business
Table 95. Viatris Latest Developments
Table 96. Kenvue Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 97. Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 98. Kenvue Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 99. Kenvue Main Business
Table 100. Kenvue Latest Developments
Table 101. Johnson & Johnson Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 103. Johnson & Johnson Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Teva Pharmaceuticals Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 107. Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 108. Teva Pharmaceuticals Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 109. Teva Pharmaceuticals Main Business
Table 110. Teva Pharmaceuticals Latest Developments
Table 111. Grunenthal Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 112. Grunenthal Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 113. Grunenthal Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 114. Grunenthal Main Business
Table 115. Grunenthal Latest Developments
Table 116. Averitas Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 117. Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 118. Averitas Pharma Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 119. Averitas Pharma Main Business
Table 120. Averitas Pharma Latest Developments
Table 121. Nitto Denko Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 122. Nitto Denko Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 123. Nitto Denko Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 124. Nitto Denko Main Business
Table 125. Nitto Denko Latest Developments
Table 126. IBSA Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 127. IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 128. IBSA Pharma Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 129. IBSA Pharma Main Business
Table 130. IBSA Pharma Latest Developments
Table 131. Teh Seng Pharmaceutical Mfg Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 132. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 133. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 134. Teh Seng Pharmaceutical Mfg Main Business
Table 135. Teh Seng Pharmaceutical Mfg Latest Developments
Table 136. BBCT Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 137. BBCT Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 138. BBCT Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 139. BBCT Pharmaceutical Main Business
Table 140. BBCT Pharmaceutical Latest Developments
Table 141. Beijing Tide Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 142. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 143. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 144. Beijing Tide Pharmaceutical Main Business
Table 145. Beijing Tide Pharmaceutical Latest Developments
Table 146. Jiudian Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 147. Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 148. Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 149. Jiudian Pharmaceutical Main Business
Table 150. Jiudian Pharmaceutical Latest Developments
Table 151. Yunnan Baiyao Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 152. Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 153. Yunnan Baiyao Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 154. Yunnan Baiyao Main Business
Table 155. Yunnan Baiyao Latest Developments
Table 156. Lingrui Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 157. Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 158. Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 159. Lingrui Pharmaceutical Main Business
Table 160. Lingrui Pharmaceutical Latest Developments
Table 161. Anhui Jinma Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 162. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 163. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 164. Anhui Jinma Pharmaceutical Main Business
Table 165. Anhui Jinma Pharmaceutical Latest Developments
Table 166. Guizhou Liansheng Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 167. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 168. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 169. Guizhou Liansheng Pharmaceutical Main Business
Table 170. Guizhou Liansheng Pharmaceutical Latest Developments
Table 171. Yabao Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 172. Yabao Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
Table 173. Yabao Pharmaceutical Non-opioid Analgesic Patch Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 174. Yabao Pharmaceutical Main Business
Table 175. Yabao Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-opioid Analgesic Patch
Figure 2. Non-opioid Analgesic Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Analgesic Patch Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Non-opioid Analgesic Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Analgesic Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patch
Figure 12. Product Picture of Diclofenac Patch
Figure 13. Product Picture of Methyl Salicylate Patch
Figure 14. Product Picture of Capsaicin Patch
Figure 15. Product Picture of Ketoprofen Patch
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Analgesic Patch Sales Market Share by Product in 2025
Figure 18. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
Figure 19. Non-opioid Analgesic Patch Consumed in Hospitals and Clinics
Figure 20. Global Non-opioid Analgesic Patch Market: Hospitals and Clinics (2020-2025) & (K Dose)
Figure 21. Non-opioid Analgesic Patch Consumed in Retail Pharmacy
Figure 22. Global Non-opioid Analgesic Patch Market: Retail Pharmacy (2020-2025) & (K Dose)
Figure 23. Non-opioid Analgesic Patch Consumed in Online Pharmacy
Figure 24. Global Non-opioid Analgesic Patch Market: Online Pharmacy (2020-2025) & (K Dose)
Figure 25. Global Non-opioid Analgesic Patch Sale Market Share by Application (2024)
Figure 26. Global Non-opioid Analgesic Patch Revenue Market Share by Application in 2025
Figure 27. Non-opioid Analgesic Patch Sales by Company in 2025 (K Dose)
Figure 28. Global Non-opioid Analgesic Patch Sales Market Share by Company in 2025
Figure 29. Non-opioid Analgesic Patch Revenue by Company in 2025 ($ millions)
Figure 30. Global Non-opioid Analgesic Patch Revenue Market Share by Company in 2025
Figure 31. Global Non-opioid Analgesic Patch Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 34. Americas Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 35. APAC Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 36. APAC Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 37. Europe Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 38. Europe Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 40. Middle East & Africa Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 41. Americas Non-opioid Analgesic Patch Sales Market Share by Country in 2025
Figure 42. Americas Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Figure 43. Americas Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 44. Americas Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 45. United States Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Non-opioid Analgesic Patch Sales Market Share by Region in 2025
Figure 50. APAC Non-opioid Analgesic Patch Revenue Market Share by Region (2020-2025)
Figure 51. APAC Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 52. APAC Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 53. China Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. India Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Non-opioid Analgesic Patch Sales Market Share by Country in 2025
Figure 61. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Figure 62. Europe Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 63. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 64. Germany Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 65. France Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 71. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 72. Egypt Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch in 2025
Figure 78. Manufacturing Process Analysis of Non-opioid Analgesic Patch
Figure 79. Industry Chain Structure of Non-opioid Analgesic Patch
Figure 80. Channels of Distribution
Figure 81. Global Non-opioid Analgesic Patch Sales Market Forecast by Region (2026-2031)
Figure 82. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Product (2026-2031)
Figure 84. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Product (2026-2031)
Figure 85. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Non-opioid Analgesic Patch
Figure 2. Non-opioid Analgesic Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Analgesic Patch Sales Growth Rate 2020-2031 (K Dose)
Figure 7. Global Non-opioid Analgesic Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Non-opioid Analgesic Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2024)
Figure 10. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lidocaine Patch
Figure 12. Product Picture of Diclofenac Patch
Figure 13. Product Picture of Methyl Salicylate Patch
Figure 14. Product Picture of Capsaicin Patch
Figure 15. Product Picture of Ketoprofen Patch
Figure 16. Product Picture of Others
Figure 17. Global Non-opioid Analgesic Patch Sales Market Share by Product in 2025
Figure 18. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
Figure 19. Non-opioid Analgesic Patch Consumed in Hospitals and Clinics
Figure 20. Global Non-opioid Analgesic Patch Market: Hospitals and Clinics (2020-2025) & (K Dose)
Figure 21. Non-opioid Analgesic Patch Consumed in Retail Pharmacy
Figure 22. Global Non-opioid Analgesic Patch Market: Retail Pharmacy (2020-2025) & (K Dose)
Figure 23. Non-opioid Analgesic Patch Consumed in Online Pharmacy
Figure 24. Global Non-opioid Analgesic Patch Market: Online Pharmacy (2020-2025) & (K Dose)
Figure 25. Global Non-opioid Analgesic Patch Sale Market Share by Application (2024)
Figure 26. Global Non-opioid Analgesic Patch Revenue Market Share by Application in 2025
Figure 27. Non-opioid Analgesic Patch Sales by Company in 2025 (K Dose)
Figure 28. Global Non-opioid Analgesic Patch Sales Market Share by Company in 2025
Figure 29. Non-opioid Analgesic Patch Revenue by Company in 2025 ($ millions)
Figure 30. Global Non-opioid Analgesic Patch Revenue Market Share by Company in 2025
Figure 31. Global Non-opioid Analgesic Patch Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 34. Americas Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 35. APAC Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 36. APAC Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 37. Europe Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 38. Europe Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Non-opioid Analgesic Patch Sales 2020-2025 (K Dose)
Figure 40. Middle East & Africa Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
Figure 41. Americas Non-opioid Analgesic Patch Sales Market Share by Country in 2025
Figure 42. Americas Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Figure 43. Americas Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 44. Americas Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 45. United States Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Non-opioid Analgesic Patch Sales Market Share by Region in 2025
Figure 50. APAC Non-opioid Analgesic Patch Revenue Market Share by Region (2020-2025)
Figure 51. APAC Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 52. APAC Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 53. China Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. India Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Non-opioid Analgesic Patch Sales Market Share by Country in 2025
Figure 61. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
Figure 62. Europe Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 63. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 64. Germany Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 65. France Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
Figure 71. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
Figure 72. Egypt Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch in 2025
Figure 78. Manufacturing Process Analysis of Non-opioid Analgesic Patch
Figure 79. Industry Chain Structure of Non-opioid Analgesic Patch
Figure 80. Channels of Distribution
Figure 81. Global Non-opioid Analgesic Patch Sales Market Forecast by Region (2026-2031)
Figure 82. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Product (2026-2031)
Figure 84. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Product (2026-2031)
Figure 85. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Zafirlukas Market Growth 2023-2029
US$ 3,660.00
February 2023
99 pages
Global Microdebride Market Growth 2024-2030
US$ 3,660.00
March 2024
101 pages
Global Orally Disintegrating Tablet Market Growth 2025-2031
US$ 3,660.00
January 2025
112 pages
Global Thoracolumbar Vertebral Corpectomy Prosthesis Market Growth 2023-2029
US$ 3,660.00
February 2023
97 pages
